Search
for
Sort by
Research 31–60 of 338
- Systemic causes of hair loss
- Telogen Effluvium
- Hidradenitis Suppurativa/Acne Inversa/Dissecting Terminal Hair Folliculitis
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- Clinical Research Progress on Plum-Blossom Needle Combined Therapy for Androgenic Alopecia
- Efficacy of Compound GV-350 with Tricofer® Iron, Cystine and Biotin in the Management of Telogen Effluvium in Women with Iron Deficiency
- Advances in dermatology research: A comprehensive literature review
- Biological Investigation of Aqueous Extract of Funnel Seeds to Check its Therapeutic Effects in the Management of Polycystic Ovarian Syndrome in Induced PCOS Female Albino Rats
- TENSILE STRENGTH OF SCALP HAIR IN WOMEN WITH HAIR LOSS
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Exploring the Inhibitory Potential of Phytosterols β-Sitosterol, Stigmasterol, and Campesterol on 5-Alpha Reductase Activity in the Human Prostate: An In Vitro and In Silico Approach
- Adipose derived stem cell based therapies or male/female pattern hair loss
- Adipose derived stem cell based therapies or male/female pattern hair loss
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Recent Advances in Drug Development for Hair Loss
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Electrospun Nanofibers for Biomedical, Sensing, and Energy Harvesting Functions
- A review of hormonal therapy for female pattern (androgenic) alopecia
- The Association Between Alopecia Areata and Iron Deficiency Anemia: A Large-Scale Population-Based Case–Control Study
- Hair Growth-Promoting Effects of a Multi-Targeted Cosmetic Formulation Containing PYGL, DP2, and 15-PGDH Inhibitors Developed Using AI-Based DeepZema® in Androgenetic Alopecia: A 24-Week Randomized Controlled Trial
- Nanotechnology-Based Strategies for Hair Regeneration: Mechanistic Insights and Translational Perspectives for Androgenetic Alopecia
- Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery